Obesity

Showing NaN - NaN of 116

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Overweight, Obesity Trial in United States (Semaglutide, Placebo (semaglutide))

Completed
  • Overweight
  • Obesity
  • Birmingham, Alabama
  • +40 more
Nov 10, 2021

Obesity, Overweight Trial in Worldwide (Semaglutide 1.0 mg, Semaglutide 2.4 mg, Placebo I (Semaglutide))

Completed
  • Obesity
  • Overweight
  • Semaglutide 1.0 mg
  • +3 more
  • Buena Park, California
  • +146 more
Nov 8, 2021

Obesity Trial in United States (AMG 598, Placebo, Liraglutide)

Completed
  • Obesity
  • AMG 598
  • +2 more
  • Birmingham, Alabama
  • +3 more
Oct 8, 2021

Obesity, Overweight Trial in Worldwide (Tirzepatide, Placebo)

Active, not recruiting
  • Obesity
  • Overweight
  • Pelham, Alabama
  • +69 more
Oct 5, 2021

Obesity Trial in Daytona Beach, Dallas (MEDI0382, Placebo)

Completed
  • Obesity
  • Daytona Beach, Florida
  • +1 more
Aug 16, 2021

Diabetes, Hypertension, Chronic Kidney Diseases Trial in Dallas (Usual Care, I-POP + CHW navigation)

Recruiting
  • Diabetes
  • +4 more
  • Usual Care
  • I-POP + CHW navigation
  • Dallas, Texas
    Baylor Research Institute
Jul 22, 2021

The SEEA (SCI Energy Expenditure and Activity) Study

Active, not recruiting
  • Spinal Cord Injuries
  • +4 more
    • Dallas, Texas
      Baylor Scott & White Institute for Rehabilitation - Dallas
    Feb 9, 2021

    Obesity, Nutrition Disorders, Overweight Trial in Dallas (Micafungin)

    Completed
    • Obesity
    • +2 more
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Nov 2, 2020

    Obalon Balloon System Post-Approval Study

    Unknown status
    • Obesity
    • Obalon Balloon System
    • Fountain Valley, California
    • +14 more
    Apr 29, 2020

    Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (semaglutide, liraglutide, )

    Completed
    • Metabolism and Nutrition Disorder
    • Obesity
    • Anaheim, California
    • +73 more
    Apr 14, 2020

    Obesity Trial in Dallas (LAP-BAND (Allergan, Inc.))

    Terminated
    • Obesity
    • LAP-BAND (Allergan, Inc.)
    • Dallas, Texas
      Children's Medical Center Dallas
    Apr 3, 2020

    Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (Liraglutide 3.0 mg, Placebo)

    Completed
    • Metabolism and Nutrition Disorder
    • Obesity
    • Liraglutide 3.0 mg
    • Placebo
    • Birmingham, Alabama
    • +53 more
    Mar 13, 2020

    Metabolism and Nutrition Disorder, Obesity Trial in United States (liraglutide, , CMS Intensive Behavior Therapy)

    Completed
    • Metabolism and Nutrition Disorder
    • Obesity
    • Jacksonville, Florida
    • +9 more
    Feb 28, 2020

    Obesity Trial in Worldwide (JNJ-64565111 Dose Level 1, JNJ-64565111 Dose Level 2, JNJ-64565111 Dose Level 3)

    Completed
    • Obesity
    • JNJ-64565111 Dose Level 1
    • +4 more
    • Phoenix, Arizona
    • +50 more
    Jan 14, 2020

    Obesity, Insulin Resistance, Vitamin D Deficiency Trial in Dallas (Vitamin D3)

    Completed
    • Obesity
    • +2 more
    • Vitamin D3
    • Dallas, Texas
      UT Southwestern Medical Center
    Nov 20, 2019

    Obesity, Heart Failure, Diastolic, Metabolic Syndrome Trial in Dallas (High intensity exercise, Omega-3 fish oil, Yoga)

    Completed
    • Obesity
    • +2 more
    • High intensity exercise
    • +3 more
    • Dallas, Texas
      The Institute for Exercise and Environmental Medicine
    Oct 11, 2019

    Obesity Trial in United States (Leu Sil 1.0mg, Leu Sil 4.0mg, Leu Met Sil 1.0mg)

    Completed
    • Obesity
    • Leu Sil 1.0mg
    • +4 more
    • Mobile, Alabama
    • +14 more
    Aug 19, 2019

    Obesity Trial in United States (TransPyloric Shuttle, Sham procedure, Lifestyle Counseling)

    Completed
    • Obesity
    • TransPyloric Shuttle
    • +2 more
    • Scottsdale, Arizona
    • +8 more
    Jul 15, 2019

    Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)

    Completed
    • Cardiovascular Disease
    • +4 more
    • Lorcaserin hydrochloride
    • Placebo
    • Alexander City, Alabama
    • +498 more
    Jun 27, 2019

    Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Fatigue Trial in Korea, Republic of, United States

    Unknown status
    • Endometrial Clear Cell Adenocarcinoma
    • +6 more
    • 3-Dimensional Conformal Radiation Therapy
    • +7 more
    • Birmingham, Alabama
    • +539 more
    Mar 8, 2019

    Cardiovascular Disease, Hypertension, Diabetes Trial in Dallas (Lay Health Promoter (LHP) with maintenance)

    Completed
    • Cardiovascular Disease
    • +3 more
    • Lay Health Promoter (LHP) with maintenance
    • Dallas, Texas
      UT Southwestern Medical Center
    Feb 8, 2019

    Metabolic Syndrome, Non-alcoholic Fatty Liver Disease, Obesity Trial in Dallas (Low-fat diet, Low-carbohydrate diet)

    Completed
    • Metabolic Syndrome
    • +2 more
    • Low-fat diet
    • Low-carbohydrate diet
    • Dallas, Texas
      Center for Human Nutrition
    Feb 4, 2019

    Obesity, Mycoses Trial in Dallas (Anidulafungin)

    Completed
    • Obesity
    • Mycoses
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Jan 8, 2019

    Obesity, Premature Recovery From Anesthesia Trial in Dallas (Nuvigil, Placebo)

    Completed
    • Obesity
    • Premature Recovery From Anesthesia
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Dec 3, 2018

    Desaturation of Blood, Obesity, Colonoscopy Trial in Dallas (The Comfort Flo system, The Salter nasal cannula)

    Completed
    • Desaturation of Blood
    • +4 more
    • The Comfort Flo system
    • The Salter nasal cannula
    • Dallas, Texas
    • +1 more
    Nov 15, 2018